1) human epidermal growth factor receptor-2
人类表皮生长因子受体-2
2) human epidermal growth factor receptor 2
人表皮生长因子受体2
1.
Objective To detect the expressions of human epidermal growth factor receptor 2 (Her-2), epidermal growth factor receptor (EGFR), presenilin 2 (PS-2) and estrogen receptor (ER) in breast cancer and discuss their clinical implications.
目的探讨人表皮生长因子受体2(Her-2)、表皮生长因子受体(EGFR)、雌激素调节蛋白(PS-2)、雌激素受体(ER) 在乳腺癌中的表达及其临床意义。
3) human epidermal receptor 2
人表皮生长因子受体2
1.
Objective To investigate the relationship between the survival time and the high-expression of epidermal growth factor receptor (EGFR) and human epidermal receptor 2 (HER2) in breast cancer patients, and assess the feasibility of using the two markers either alone or in combination for predicting the prognosis of the patients.
目的研究乳腺癌人表皮生长因子受体2(Her2)和表皮生长因子受体(EGFR)高表达与生存期的关系,探讨其单独或联合作为预后指标的可行性。
4) human epithelial growth factor receptor-2
人表皮生长因子受体-2
1.
Objective: To identify molecular markers epithelial growth factor receptor(EGFR) and human epithelial growth factor receptor-2(HER2) to predict the sensitivity of chemoradiotherapy(CRT)in the esophageal squamous cell carcinoma(ESCC).
目的:研究分子标记物表皮生长因子受体(EGFR)、人表皮生长因子受体-2(HER2)预测食管鳞状细胞癌同步放化疗敏感性的价值。
6) human epithelial growth factor receptor 2 (HER2)
人类表皮生长因子受体2
1.
Objective To evaluate the effect of herceptin(transtuzumab) plus adjuvant chemotherapy on the prognosis of patients with human epithelial growth factor receptor 2 (HER2) positive early-stage breast cancer by Meta-analysis.
目的:应用meta分析的方法探讨赫赛汀(曲妥珠单抗)联合辅助化疗对人类表皮生长因子受体2(HER2)阳性早期乳腺癌患者预后的影响。
补充资料：人类
1.泛指人。 2.人的总称，指人的全体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条